MedTrace Logo

Naldebain and Video-assisted Thoracoscopic Surgery

NCT04962152 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-21

No results posted yet for this study

Summary

To evaluate the postoperative analgesic effect of combined use of Naldebain® and thoracic paravertebral block in thoracoscopic surgery

Conditions

  • Analgesia
  • Nausea and Vomiting, Postoperative
  • Itching
  • Injection Site Reaction
  • Satisfaction, Patient

Interventions

DRUG

Nalbuphine Sebacate or Sesame oil (placebo)

ultrasound-guided intramuscular injection after the induction of anesthesia immediately

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Hung-Te Hsu, MD, PhD · Department of anesthesiology, Kaohsiung Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2024-05-07
Completion
2024-05-07

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962152 on ClinicalTrials.gov